Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 40/73 ]
NASDAQ | Common Stock
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
The company also offers VivoScore Program, a screening and home sleep test in adults and children.
It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada.
Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 19, 25 | -0.49 Decreased by -22.50% | -0.48 Decreased by -2.08% |
| Aug 19, 25 | -0.55 Increased by +8.33% | -0.39 Decreased by -41.03% |
| May 12, 25 | -0.48 Increased by +70.55% | -0.40 Decreased by -20.00% |
| Mar 26, 25 | -0.28 Increased by +90.82% | -0.43 Increased by +34.88% |
| Nov 12, 24 | -0.40 Increased by +75.31% | -0.61 Increased by +34.43% |
| Aug 14, 24 | -0.60 Decreased by -233.33% | -1.05 Increased by +42.86% |
| May 14, 24 | -1.63 Decreased by -2.23 K% | -1.17 Decreased by -39.32% |
| Mar 28, 24 | -3.05 Decreased by -1.42 K% | -1.90 Decreased by -60.53% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 6.78 M Increased by +75.73% | -5.40 M Decreased by -106.42% | Decreased by -79.61% Decreased by -17.47% |
| Jun 30, 25 | 3.82 M Decreased by -5.77% | -5.01 M Decreased by -159.74% | Decreased by -131.23% Decreased by -175.65% |
| Mar 31, 25 | 3.02 M Decreased by -11.79% | -3.86 M Decreased by -2.68% | Decreased by -128.12% Decreased by -16.40% |
| Dec 31, 24 | 3.70 M Increased by +13.85% | -2.83 M Increased by +33.62% | Decreased by -76.45% Increased by +41.70% |
| Sep 30, 24 | 3.86 M Increased by +16.93% | -2.62 M Decreased by -24.99% | Decreased by -67.77% Decreased by -6.89% |
| Jun 30, 24 | 4.05 M Increased by +19.41% | -1.93 M Increased by +65.09% | Decreased by -47.61% Increased by +70.76% |
| Mar 31, 24 | 3.42 M Decreased by -11.36% | -3.76 M Decreased by -178.82% | Decreased by -110.06% Decreased by -188.92% |
| Dec 31, 23 | 3.25 M Decreased by -17.77% | -4.26 M Increased by +41.67% | Decreased by -131.13% Increased by +29.06% |